Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy D Lin

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
BMC Pediatrics|November 30, 2005
Impact of the introduction of pneumococcal conjugate vaccine on immunization coverage among infantsNancy D Lin, Ken Kleinman, K Arnold Chan, et al.
Plos One|July 20, 2022
Trends in COVID-19 patient characteristics in a large electronic health record database in the United States: A cohort studyCaihua Liang, Rachel P Ogilvie, Michael Doherty, et al.
BMC Pediatrics|November 15, 2006
Variation in hepatitis B immunization coverage rates associated with provider practices after the temporary suspension of the birth doseNancy D Lin, Ken Kleinman, K Arnold Chan, et al.
BMC Infectious Diseases|April 29, 2022
Predictors of critical care, mechanical ventilation, and mortality among hospitalized patients with COVID-19 in an electronic health record databaseAndrea K Chomistek, Caihua Liang, Michael C Doherty, et al.
The Hastings Center Report|August 21, 2019
Bystander Ethics and Good Samaritanism: A Paradox for Learning Health OrganizationsJames E Sabin, Noelle M Cocoros, Crystal J Garcia, et al.
Journal of Managed Care & Specialty Pharmacy|September 25, 2024
Utilization and patient characteristics for the trastuzumab reference and biosimilars, and other human epidermal growth factor receptor 2 inhibitors in the United StatesXiaodan Mai, Aaron B Mendelsohn, James Marshall, et al.
Clinical Trials (London, England)|June 27, 2020
Practical challenges in the conduct of pragmatic trials embedded in health plans: Lessons of IMPACT-AFib, an FDA-Catalyst trialCrystal J Garcia, Kevin Haynes, Sean D Pokorney, et al.
Vaccine|November 10, 2015
Evaluation of the risk of venous thromboembolism after quadrivalent human papillomavirus vaccination among US femalesW Katherine Yih, Sharon K Greene, Lauren Zichittella, et al.
American Heart Journal|September 19, 2020
Underuse of oral anticoagulants in privately insured patients with atrial fibrillation: A population being targeted by the IMplementation of a randomized controlled trial to imProve treatment with oral AntiCoagulanTs in patients with Atrial Fibrillation (IMPACT-AFib)Sana M Al-Khatib, Sean D Pokorney, Hussein R Al-Khalidi, et al.
Clinical Trials (London, England)|November 18, 2018
FDA-Catalyst-Using FDA's Sentinel Initiative for large-scale pragmatic randomized trials: Approach and lessons learned during the planning phase of the first trialNoelle M Cocoros, Sean D Pokorney, Kevin Haynes, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
BMC Pediatrics|November 30, 2005
Impact of the introduction of pneumococcal conjugate vaccine on immunization coverage among infantsNancy D Lin, Ken Kleinman, K Arnold Chan, et al.
Plos One|July 20, 2022
Trends in COVID-19 patient characteristics in a large electronic health record database in the United States: A cohort studyCaihua Liang, Rachel P Ogilvie, Michael Doherty, et al.
BMC Pediatrics|November 15, 2006
Variation in hepatitis B immunization coverage rates associated with provider practices after the temporary suspension of the birth doseNancy D Lin, Ken Kleinman, K Arnold Chan, et al.
BMC Infectious Diseases|April 29, 2022
Predictors of critical care, mechanical ventilation, and mortality among hospitalized patients with COVID-19 in an electronic health record databaseAndrea K Chomistek, Caihua Liang, Michael C Doherty, et al.
The Hastings Center Report|August 21, 2019
Bystander Ethics and Good Samaritanism: A Paradox for Learning Health OrganizationsJames E Sabin, Noelle M Cocoros, Crystal J Garcia, et al.
Journal of Managed Care & Specialty Pharmacy|September 25, 2024
Utilization and patient characteristics for the trastuzumab reference and biosimilars, and other human epidermal growth factor receptor 2 inhibitors in the United StatesXiaodan Mai, Aaron B Mendelsohn, James Marshall, et al.
Clinical Trials (London, England)|June 27, 2020
Practical challenges in the conduct of pragmatic trials embedded in health plans: Lessons of IMPACT-AFib, an FDA-Catalyst trialCrystal J Garcia, Kevin Haynes, Sean D Pokorney, et al.
Vaccine|November 10, 2015
Evaluation of the risk of venous thromboembolism after quadrivalent human papillomavirus vaccination among US femalesW Katherine Yih, Sharon K Greene, Lauren Zichittella, et al.
American Heart Journal|September 19, 2020
Underuse of oral anticoagulants in privately insured patients with atrial fibrillation: A population being targeted by the IMplementation of a randomized controlled trial to imProve treatment with oral AntiCoagulanTs in patients with Atrial Fibrillation (IMPACT-AFib)Sana M Al-Khatib, Sean D Pokorney, Hussein R Al-Khalidi, et al.
Clinical Trials (London, England)|November 18, 2018
FDA-Catalyst-Using FDA's Sentinel Initiative for large-scale pragmatic randomized trials: Approach and lessons learned during the planning phase of the first trialNoelle M Cocoros, Sean D Pokorney, Kevin Haynes, et al.
Pageof 3